Buyer's Guide
Country:
Zipcode:
Operation:
Search for:
Companies Products Countries ZIP Code (Germany) New Companies
0-9   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Print version | PDF version | Recommend company

Xanthus Pharmaceuticals, Inc.
300 Technology Square
02139 Cambridge, MA
United States of America

Phone:  +1617225-0522
Fax:  +1617225-0525

Portrait
Xanthus Pharmaceuticals, Inc. is developing a portfolio of novel, clinical-stage, small-molecule therapeutic candidates through a management team whose accomplished track record encompasses all aspects of drug development, from discovery through regulatory approval and commercialisation. The Company is applying its expertise to advance its current pipeline to address significant unmet medical need in oncology and autoimmune diseases. Xanthus is headquartered in Cambridge, Massachusetts with an additional facility in Montreal, Quebec.

Industrial Sectors
  • Pharmacy

       
      Additional information

      Xanthus Pharmaceuticals, Inc.
      Cambridge, MA, United States of America

      News
      - 20 May 2008 - Antisoma to acquire Boston-based Xanthus Pharmaceuticals
      - 13 Apr 2007 - Xanthus acquires from John Hopkins University exclusive license to patent estate covering FLT3 pathway
      - 20 Sep 2006 - Xanthus Presents In Vitro Data Demonstrating that Symadex is a Potent and Selective Inhibitor of FLT3
       more news
      MyBionity.COM
      Newsletter Subscription
      Your e-mail:
      Top  
      © 2001-2008 Chemie.DE Information Service GmbH
      a Life Science Network Division

       www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET